JAMA (Yang, Y., et al. )10. 24. 2023 published an original investigation “Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.” Investigators of this clinical study conducted a randomized, double-blind, placebo-controlled clinical trial of 3777 patients with acute ST-segment elevation myocardial infarction (STEMI). Patients from 124 hospitals in China presenting with STEMI between May-December 2020 were given either oral Tongxinluo or placebo within 24 hours of symptom onset. The adjunctive treatment or placebo was administered for 12 months, and positive patient outcome was observed.
The LDA offers a wide variety of resources, many free. Download and print free brochures, pie graphs and maps, order free handouts or low cost books, view and/or purchase scientific conference videos, access information on Lyme and kids and schools, apply for LymeAid 4 Kids funds for children without insurance for Lyme disease, read articles on disability and medical insurance, and view tick-borne diseases rash photos. Access the LDA’s Conflicts of Interest in Lyme Disease: Laboratory Testing, Vaccination, and Treatment Guidelines, written by author Pamela Weintraub for the LDA in 2001, years before her book, Cure Unknown Inside the Lyme Disease Epidemic, was published.
We are constantly trying to provide products and services to help raise awareness. Here are the top ten picks over time.